Michel Rubinstein


 

 





CURRICULUM VITAE
Au 31 Octobre 2004

Nom : RUBINSTEIN

Prénom : Michel

Date de naissance : 20.10.1957

 


Etudes secondaires :

1969 - 1975 : Athénée Royal de Charleroi (Section Latin-Mathématiques)

Etudes universitaires :

1975 - 1982 : Etudes de Médecine à l'Université Libre de Bruxelles (U.L.B.)
(5 G.D ; 2 L.P.G.D. ; 1 Prix Fl. Mercier)

Etudes post-universitaires :

1982 - 1985 : Licence en Médecine Interne à l'Hôpital Erasme

1985 - 1988 : Licence en Médecine Nucléaire à l'U.L.B.
Reconnu nucléariste le 26.06.1988

1985 - 1986 : Licence Spéciale en Radioprotection à l'U.L.B.

05/02-10/02 : Formation en PET-SCAN (ULB Erasme - professeur S. Goldman)

Numéro d'agréation INAMI en Médecine Nucléaire : 1-29027-80-970

 

Activité professionnelle :

- 1988 à ce jour : Département de Médecine Nucléaire de l'Hôpital d'Ixelles

- Depuis 11/1993 : Responsable de ce Département.

- Depuis 1992 : Responsable du Département de Médecine Nucléaire du Site Brien Hôpital Brugmann.

- Depuis 1997 : Expert près le Tribunal du Travail de Bruxelles

Egalement Administrateur de la Clinique Antoine Depage.

 

Publications scientifiques et participation aux congrès internationaux

Manuel de Médecine Nucléaire :
M. Rubinstein, E. Laurent, M. Stegen
Ed. De Boeck Université, 2000

Quantification of the age-dependent changes in cerebral metabolites : neonatal and hypothyroid rats.
M. Rubinstein & al.
In " Characterization of Biological Tissues by MNR ", EEC Press, 1998.

Desferrioxamine Ocular Toxicity and Chronic Renal Failure.
M. Rubinstein & al. - The Lancet, 1985, 1, 817-818.

Longitudinal Observation of Seasonal Variations of Platelet Serotonin Uptake and Imipramine Binding in Normal and Depressed Subjects.
M. Rubinstein, D. Egrise, & al. - Biol. Psych., 1986, 4, 758-766.

Mesure du volume ventriculaire gauche au moyen d'un standard interne et d'une incidence.
M. Rubinstein & al. - J. Biophys. et Bioméc., 1987 , 11, 2.

The Validity of P31-MRS as a Tool for the Study of Congenital Hypothyroidism in Neonate Rats.
M. Rubinstein & al. In " Research in Congenital Hypothyroidism ", NATO ASI Series, 1988, p. 321.

Single Photon Emission Computed Tomography in Seizure Disorders.
M. Rubinstein, R. Denays, & al. - Archives of Disease in Childhood, 1988, 63, 1184-1188.

Functional Imaging of Brain Maturation in Humans Using 123I-IMP and SPECT.
M. Rubinstein & al. The Journal of Nuclear Medicine, 1989, 30, 1982-1985.

Evaluation of Suspected Dementia.
M. Rubinstein & al., N. Eng. J. Med., 1996, p. 1997 (letter).

Adherence to Imaging Protocol and Impact of Training on the Interpretation of CEA-Scan (Arcitumomab) Imaging for colorectal Cancer.
M. Rubinstein, M. VanDaele, P. Wegener; Alasbimn Jounal 6(25) : july 2004.

Clinical Use of Prostaglandin Synthesis Inhibitors in SIADH.
M. Rubinstein & al., XXIInd Congress of the EDTA-European Renal Association, 1985.

The Pronostic Value of Various Liver Testss in Alcoolic Liver Cirrhosis.
M. Rubinstein & al., European Nuclear Medicine Congress, Budapest, 1987.

A P31-MRS Study of Congenital Hypothyroidism in Neonate Rats.
M. Rubinstein & al., American Academy of Neurology, XXXth Annual Meeting, Cincinnati, 1988.

Brain Maturation in Human Newborns : a Cerebral Blood Flow (CBF) Study Using 123I-IMP and SPECT.
M. Rubinstein & al., The Society of Nuclear Medicine, 35th Meeting, San Francisco, 1988.

Cerebral Blood Flow Imaging of Brain Maturation in Humans Using 123I-IMP and SPECT.
M. Rubinstein & al., European Nuclear Medicine Congress, Milano, 1988.

SPECT Study of Cerebral Blood Flow (CBF) Perturbations in Childhood Seizure Disorders.
M. Rubinstein & al., European Nuclear Medicine Congress, Milano, 1988.

Tc-99m-Nanocolloids : an Alternative Approach to Diagnosis of Inflammatory Lesions of Bones and Joints.
M. Rubinstein & al., European Nuclear Medicine Congress, Milano, 1988.

Combined CBF/CBV SPECT Study in Recent and Old Strokes .
M. Rubinstein & al., The Society of Nuclear Medicine, 36th Meeting, Saint-Louis, 1989.

Remote Cortical Effects of Deep Lesions Involving the Pyramidal Tract : a rCBF Study Using 99mTc-HMPAO.
M. Rubinstein & al., 5th World Congress of Nuclear Medicine and Biology, Montreal, 1990.

Interactive 3-D Display in 99mTc-HMPAO Brain SPECT.
M. Rubinstein & al., 5th World Congress of Nuclear Medicine and Biology, Montreal, 1990.

Has 99mTc-HMPAO Brain SPECT a Place in the Routine Work-up of Epilepsy ?
M. Rubinstein & al., 5th World Congress of Nuclear Medicine and Biology, Montreal, 1990.

Combined CBF/CBV SPECT Study in Recent and Old Strokes.
M. Rubinstein & al., 5th World Congress of Nuclear Medicine and Biology, Montreal, 1990.

Left Ventricular Wall Thickening Measurement Using Tc-99m-MIBI and Gated SPECT : Feasibility and Comparison with Other Imaging Techniques.
M. Rubinstein & al. - 5th World Congress of Nuclear Medicine and Biology, Montreal, 1990.

Evaluation of Tc-99m HMPAO Brain SPECT (SPECT) In Minor Closed Head Traumas (MCHT) and Comparison with EERG.
M. Rubinstein & al. - The Society of Nuclear Medicine, 41st Annual Meeting, Orlando, 1994.

Clinical Assessment of Liver Function and Porto-Systemic Shunt : a Quantitative 99mTc-IDA Hepatobiliary Scintigraphic (Q-HBS) Study.
M. Rubinstein & al., The Society of Nuclear Medicine, 42nd Annual Meeting, Minneapolis, 1995.

Comparison of CBV/CBF SPECT and Diamox 99mTc ECD SPECT in Patients with Unilateral Carotid Stenosis.
M. Rubinstein & al., The Society of Nuclear Medicine, 43rd Meeting, Denver, 1996.

Impact of Training on the Interpretation of CEA-scan of Patients with Colo-Rectal Cancer.
M. Rubinstein & al., Annual Meeting of the Eur. Assoc. Of Nuclear Medicine, Berlin, 1998 (Invited Lecturer).